BRIEF published on 08/25/2026 at 19:35, 2 months 11 days ago New CEO Appointed at KD Pharma Group Pharmaceutical Industry Leadership Change KD Pharma Group Omega-3 Lipids Manja Boerman
PRESS RELEASE published on 08/25/2026 at 19:30, 2 months 11 days ago Change in the Management Board O3 Holding GmbH announces the appointment of Manja Boerman as Chief Executive Officer of KD Pharma Group, bringing extensive industry expertise in pharmaceutical, biotechnology, and life sciences Pharmaceutical Industry Chief Executive Officer O3 Holding GmbH KD Pharma Group Manja Boerman
BRIEF published on 08/21/2026 at 15:20, 2 months 16 days ago O3 Holding GmbH Releases Q2 2026 Interim Report Bond Issue O3 Holding GmbH KD Pharma Group Q2 2026 Report Pharmaceutical Lipids
PRESS RELEASE published on 08/21/2026 at 15:15, 2 months 16 days ago O3 Holding GmbH - Publication Q2 2026 Interim Report O3 Holding GmbH, the parent company of KD Pharma Group, releases Q2 2026 Interim Report in compliance with bond terms, available on their website Pharmaceutical O3 Holding GmbH KD Pharma Group Q2 2026 Interim Report Nutritional Lipids
BRIEF published on 05/29/2026 at 18:05, 5 months 7 days ago O3 Holding GmbH Releases Q1 2026 Interim Report Financial Disclosure Bond Issue O3 Holding GmbH KD Pharma Group Q1 2026 Report
PRESS RELEASE published on 05/29/2026 at 18:00, 5 months 7 days ago O3 Holding GmbH - Publication Q1 2026 Interim Report O3 Holding GmbH announces the publication of its Q1 2026 Interim Report for its FRN Senior Secured EUR 180,000,000 bond issue. Contact investor.relations@kdpharma.com for more info CDMO Interim Report Q1 2026 O3 Holding GmbH KD Pharma Group
BRIEF published on 03/02/2026 at 11:40, 8 months 4 days ago O3 Holding GmbH Releases Q4 2025 Interim Report Financial Results Bond Issue O3 Holding GmbH KD Pharma Group Q4 2025 Interim Report
PRESS RELEASE published on 03/02/2026 at 11:35, 8 months 4 days ago EQS-Adhoc: O3 Holding GmbH: O3 Holding GmbH - Publication Q4 2025 Interim Report O3 Holding GmbH, the holding company of KD Pharma Group, releases the Q4 2025 Interim Report as per bond terms. For more information, visit the company's investor relations webpage Financial Results Interim Report Q4 2025 O3 Holding GmbH KD Pharma Group
BRIEF published on 01/02/2026 at 08:35, 10 months 4 days ago O3 Holding GmbH Acquires Food-Grade Oil Business from dsm-firmenich Acquisition Dsm-firmenich O3 Holding GmbH Food-grade Oil KD Pharma Group
PRESS RELEASE published on 01/02/2026 at 08:30, 10 months 4 days ago EQS-Adhoc: O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm- firmenich financed through shareholder loan O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm-firmenich through shareholder loan. Transaction closing today Acquisition Shareholder Loan O3 Holding GmbH Food-grade Oil KD Pharma Group
Published on 11/06/2026 at 13:00, 3 hours 5 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 3 hours 35 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 3 hours 35 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 10 hours 50 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 14:50, 1 hour 15 minutes ago New UN guide keeps people in charge of AI in smart cities
Published on 11/06/2026 at 14:45, 1 hour 20 minutes ago Ningbo Consensus on Collaborative Development released at 2026 Global Mayors Dialogue · Ningbo
Published on 11/06/2026 at 14:40, 1 hour 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/05/2026 at 18:21, 21 hours 43 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 22 hours 20 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 22 hours 36 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
